Understanding of the molecular and physiological functions of Pex11 gene and etiology of dyslipidaemia and obesity, will facilitate the development of therapeutic strategies of targeting Pex11a for dyslipidaemia and obesity. This evidence concerns the gene PEX11A and obesity due to melanocortin 4 receptor deficiency.